Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Recognize when index signals hint at a trend reversal and how to adjust exposure accordingly. This guidance helps protect gains and minimize losses.
24,330 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Big-name bets via 13F filings often reveal more about risk management than marketing hype. This quarter, billionaire ...
Broadcom reported solid earnings, yet its stock slid sharply. This article breaks down what happened, why the market ...
Prime Day returns this June with a four-day stretch that doubles the window for spending signals. Here’s how investor...
A low-priced stock can spark big gains, but it requires solid research and a disciplined plan. This guide breaks down...
A broad pullback in semiconductors gave way to a cautious rally for Sandisk. This article breaks down what sparked th...
Avantis U.S. Large Cap Value ETF (AVLV) has outpaced peers with a profitability-driven screen, posting a 24.5% gain o...
Nio delivered a staggering 129% jump in EV sales, yet its stock slid in May. This analysis breaks down the drivers be...
A recent filing shows Meros Investment Management sold a sizable block of Photronics shares. Learn what this kind of ...
WWDC 2026 sparked a hot debate: can Apple sustain profits without bold hardware innovation? This guide breaks down th...
Tech-led selling pushed the Nasdaq Composite lower as investors weigh higher yields and fresh data. The broader marke...
The U.S. government has imposed export controls on Anthropic’s Fable and Mythos, effectively creating a licensing reg...